• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌中的抑郁症状与较短生存期:白细胞端粒长度的作用

Depressive symptoms and shorter survival in lung cancer: the role of leukocyte telomere length.

作者信息

Siwik Chelsea J, Cash Elizabeth, Sephton Sandra E

机构信息

Osher Center for Integrative Medicine, University of California, San Francisco, CA, USA.

Department of Otolaryngology-Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, Louisville, KY, USA.

出版信息

Psychol Health. 2023 Nov-Dec;38(12):1649-1664. doi: 10.1080/08870446.2022.2040500. Epub 2022 Mar 3.

DOI:10.1080/08870446.2022.2040500
PMID:35240880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9440155/
Abstract

OBJECTIVE

To examine the association between depressive symptoms, leukocyte telomere length-a marker of cellular ageing, and survival amongst lung cancer patients.

DESIGN

Patients with non-small cell lung cancer were recruited from a university-affiliated cancer center clinic.

MAIN OUTCOME

Patients ( = 67) reported on depressive symptoms and provided a blood sample for leukocyte telomere length assessment at baseline and at a 3-month follow-up. Survival status was tracked over 3 years.

RESULTS

Age at diagnosis and depressive symptoms, as measured by the CES-D, were associated with shorter leukocyte telomere length ( < .05), although only age at diagnosis contributed statistical significance to the model. Depressive symptoms predicted shorter survival from date of diagnosis ( < .01). Patients who reported experiencing clinically meaningful levels of depressive symptoms (CES-D scores ≥ 16) demonstrated shorter survival than those who reported sub-clinical levels of depressive symptoms ( < .05). Leukocyte telomere length did not emerge as a predictor of shorter survival.

CONCLUSION

Clinically meaningful levels of depressive symptoms are associated with shorter survival amongst lung cancer patients. These findings support the on-going efforts to screen all cancer patients for low mood and to investigate mechanisms linking depressive symptoms and shorter survival in cancer contexts.

摘要

目的

研究肺癌患者的抑郁症状、白细胞端粒长度(细胞衰老的一个标志物)与生存率之间的关联。

设计

从一所大学附属医院的癌症中心诊所招募非小细胞肺癌患者。

主要结果

67名患者报告了抑郁症状,并在基线期和3个月随访时提供血样用于白细胞端粒长度评估。对其3年的生存状况进行跟踪。

结果

通过流调中心抑郁量表(CES-D)测得的诊断时年龄和抑郁症状与较短的白细胞端粒长度相关(P<0.05),不过只有诊断时年龄对模型具有统计学意义。抑郁症状预示着自诊断之日起生存期较短(P<0.01)。报告有临床显著水平抑郁症状(CES-D评分≥16)的患者比报告有亚临床水平抑郁症状的患者生存期更短(P<0.05)。白细胞端粒长度并未成为生存期较短的预测因素。

结论

临床显著水平的抑郁症状与肺癌患者较短的生存期相关。这些发现支持持续努力对所有癌症患者进行情绪低落筛查,并研究在癌症背景下将抑郁症状与较短生存期联系起来的机制。

相似文献

1
Depressive symptoms and shorter survival in lung cancer: the role of leukocyte telomere length.肺癌中的抑郁症状与较短生存期:白细胞端粒长度的作用
Psychol Health. 2023 Nov-Dec;38(12):1649-1664. doi: 10.1080/08870446.2022.2040500. Epub 2022 Mar 3.
2
Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based study.抑郁症状与白细胞端粒长度无关:来自基于人群的新斯科舍省健康调查 (NSHS95) 的研究结果。
PLoS One. 2012;7(10):e48318. doi: 10.1371/journal.pone.0048318. Epub 2012 Oct 25.
3
Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients.抑郁症状和端粒长度缩短与膀胱癌患者死亡率增加有关。
Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):336-43. doi: 10.1158/1055-9965.EPI-14-0992. Epub 2014 Nov 21.
4
Depressive symptoms are associated with leukocyte telomere length in American Indians: findings from the Strong Heart Family Study.抑郁症状与美国印第安人的白细胞端粒长度相关:强心脏家族研究的结果
Aging (Albany NY). 2016 Nov 18;8(11):2961-2970. doi: 10.18632/aging.101104.
5
Telomere length and psychological well-being in patients with chronic heart failure.端粒长度与慢性心力衰竭患者的心理健康。
Age Ageing. 2010 Mar;39(2):223-7. doi: 10.1093/ageing/afp256. Epub 2010 Jan 19.
6
Polygenic risk score of shorter telomere length and risk of depression and anxiety in women.端粒长度较短的多基因风险评分与女性抑郁和焦虑的风险。
J Psychiatr Res. 2018 Aug;103:182-188. doi: 10.1016/j.jpsychires.2018.05.021. Epub 2018 May 26.
7
Association between anxiety but not depressive disorders and leukocyte telomere length after 2 years of follow-up in a population-based sample.在基于人群的样本中,经过 2 年的随访,焦虑症但不是抑郁症与白细胞端粒长度之间存在关联。
Psychol Med. 2013 Apr;43(4):689-97. doi: 10.1017/S0033291712001766. Epub 2012 Aug 9.
8
Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study.冠心病患者的抑郁与白细胞端粒长度:来自“心脏与灵魂研究”的数据。
Psychosom Med. 2011 Sep;73(7):541-7. doi: 10.1097/PSY.0b013e31821b1f6e. Epub 2011 May 19.
9
Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.循环白细胞端粒长度与结直肠癌患者生存的关系。
J Geriatr Oncol. 2022 May;13(4):480-485. doi: 10.1016/j.jgo.2021.12.008. Epub 2022 Jan 5.
10
Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.供体白细胞端粒长度与严重再生障碍性贫血无关供者异基因造血细胞移植后生存率之间的关联
JAMA. 2015 Feb 10;313(6):594-602. doi: 10.1001/jama.2015.7.

引用本文的文献

1
Systematic review of associations between anxiety, depression, and functional/biological aging among cancer survivors.癌症幸存者中焦虑、抑郁与功能/生物衰老之间关联的系统评价。
JNCI Cancer Spectr. 2024 Nov 1;8(6). doi: 10.1093/jncics/pkae100.
2
A novel telomere-related gene prognostic signature for survival and drug treatment efficiency prediction in lung adenocarcinoma.一种新型端粒相关基因预后标志物,可预测肺腺癌患者的生存和药物治疗效果。
Aging (Albany NY). 2023 Aug 16;15(16):7956-7973. doi: 10.18632/aging.204877.
3
Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer.在临床实践中使用情绪功能来检测晚期胸腹部和结直肠癌患者的心理困扰。
Health Qual Life Outcomes. 2023 Feb 17;21(1):15. doi: 10.1186/s12955-023-02099-w.

本文引用的文献

1
Immunotherapy in non-small cell lung cancer: Update and new insights.非小细胞肺癌的免疫治疗:最新进展与新见解
J Clin Transl Res. 2021 Jan 20;7(1):1-21. eCollection 2021 Feb 25.
2
Major Depression and Survival in People With Cancer.癌症患者中的重度抑郁症与生存。
Psychosom Med. 2021 Jun 1;83(5):410-416. doi: 10.1097/PSY.0000000000000942.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Prognostic implications of depression and inflammation in patients with metastatic lung cancer.转移性肺癌患者抑郁和炎症的预后意义。
Future Oncol. 2021 Jan;17(2):183-196. doi: 10.2217/fon-2020-0632. Epub 2020 Dec 11.
5
Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.头颈部鳞状细胞癌患者根治性治疗前后外周血中端粒酶活性的变化
Rep Pract Oncol Radiother. 2020 Jan-Feb;25(1):28-34. doi: 10.1016/j.rpor.2019.10.011. Epub 2019 Dec 1.
6
Association of pre-existing depression with all-cause, cancer-related, and noncancer-related mortality among 5-year cancer survivors: a population-based cohort study.5 年癌症幸存者中,预先存在的抑郁与全因、癌症相关和非癌症相关死亡率的关联:一项基于人群的队列研究。
Sci Rep. 2019 Dec 4;9(1):18334. doi: 10.1038/s41598-019-54677-y.
7
Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies.抑郁和焦虑与癌症发病率和死亡率的关系:队列研究的系统评价和荟萃分析。
Mol Psychiatry. 2020 Jul;25(7):1487-1499. doi: 10.1038/s41380-019-0595-x. Epub 2019 Nov 19.
8
The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature.癌症治疗对端粒长度的影响:文献系统综述。
J Natl Cancer Inst. 2018 Oct 1;110(10):1048-1058. doi: 10.1093/jnci/djy189.
9
Telomere Length and All-Cause Mortality: A Meta-analysis.端粒长度与全因死亡率:一项荟萃分析。
Ageing Res Rev. 2018 Dec;48:11-20. doi: 10.1016/j.arr.2018.09.002. Epub 2018 Sep 22.
10
Relative telomere length and prostate cancer mortality.端粒相对长度与前列腺癌死亡率。
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):579-583. doi: 10.1038/s41391-018-0068-3. Epub 2018 Aug 6.